Lack of comprehension of common prostate cancer terms in an underserved population

Journal of Clinical Oncology

Volumn 27, Issue 12, 2009, Pages 2015-2021

  Kilbridge, Kerry L ^a   Fraser, Gertrude ^b   Krahn, Murray ^c   Nelson, Elizabeth M ^d   Conaway, Mark ^e   Bashore, Randall ^f   Wolf, Andrew ^g   Barry, Michael J ^h   Gong, Debra A ⁱ   Nease Jr , Robert F ^a   Connors, Alfred F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d Central Virginia Community Health Center   (United States)

^e JESSE BROWN VA MEDICAL CENTER   (United States)

^f WASHINGTON UNIVERSITY   (United States)

^g Express Scripts   (United States)

^h METROHEALTH MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AFRICAN AMERICAN; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CORRELATION ANALYSIS; HEALTH EDUCATION; HUMAN; INFORMED CONSENT; INSTRUMENT; INTERVIEW; INTESTINE FUNCTION; KIDNEY FUNCTION; LANGUAGE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; NOMENCLATURE; OUTCOME ASSESSMENT; PATIENT EDUCATION; PRIORITY JOURNAL; PROSTATE CANCER; QUALITATIVE ANALYSIS; QUALITY OF LIFE; READING; SEXUAL FUNCTION; STATISTICAL SIGNIFICANCE;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; EDUCATIONAL STATUS; HUMANS; MALE; MEDICALLY UNDERSERVED AREA; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SOCIOECONOMIC FACTORS;

EID: 65349175937     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.17.3468     Document Type: Article

References (69)

1. Jemal A, Siegel R, Ward E, et al: Cancer Statistics, 2008. CA: Cancer J Clin 58:71-96, 2008
2. Ward E, Jemal A, Cokkinides V, et al: Cancer disparities by race/ethnicity and socioeconomic status. CA: Cancer Journal for Clinicians 54:78-93, 2004
3. Barry MJ: The PSA conundrum. Arch Intern Med 166:7-8, 2006
4. Wilkinson S, Chodak G: Informed consent for prostate-specific antigen screening. Urology 61:2-4, 2003
5. Wilt TJ, MacDonald R, Rutks I, et al: Systematic review: Comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 148:435-448, 2008
6. Harris R, Lohr KN: Screening for prostate cancer: An update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137:917-929, 2002
7. Quek ML, Penson DF: Quality of life in patients with localized prostate cancer. Urologic Oncology 23:208-215, 2005
8. Kattan MW, Cowen ME, Miles BJ: A decision analysis for treatment of clinically localized prostate cancer. J Gen Intern Med 12:299-305, 1997
9. Krahn MD, Mahoney JE, Eckman MH, et al: Screening for prostate cancer: A decision analytic view. JAMA 272:773-780, 1994
10. Fleming C, Wasson JH, Albertsen PC, et al: A decision analysis of alternative treatment strategies for clinically localized prostate cancer. JAMA 269: 2650-2658, 1993
11. Cantor SB, Spann SJ, Volk RJ, et al: Prostate cancer screening: A decision analysis. J Family Pract 41:33-41, 1995
12. Sanda MG, Dunn RL, Michalski J, et al: Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358:1250-1261, 2008
13. Litwin MS, Hays RD, Fink A, et al: Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 273:129-135, 1995
14. Talcott JA, Rieker P, Clark JA, et al: Patient-reported symptoms after primary therapy for early prostate cancer: Results of a prospective cohort study. J Clin Oncol 16:275-283, 1998
15. Fowler FJ Jr, Barry MJ, Lu-Yao G, et al: Effect of radical prostatectomy for prostate cancer on patient quality of life: Results from a Medicare survey. Urology 45:1007-1013, 1995; discussion 1013-1015, 1995
16. Potosky AL, Davis WW, Hoffman RM, et al: Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: The prostate cancer outcomes study. J Natl Cancer Inst 96:1358-1367, 2004
17. Smith RA, Cokkinides V, Eyre HJ: American Cancer Society guidelines for the early detection of cancer, 2006 CA. Cancer Journal for Clinicians 56: 11-25, 2006
18. Canadian Cancer Society: Understanding the Pros and Cons of Prostate Testing, 2008. http://www .cancer.ca/ccs/internet/standard/0,3182,3172-13271- 1858613010-langId-en,00.html
19. Carroll P, Coley C, McLeod D, et al: For the American Urological Association: Prostate-specific antigen best practice policy-part I: Early detection and diagnosis of prostate cancer. Urology 57:217-224, 2001
20. National Cancer Institute: Prostate Cancer: Screening, Health Professional Version, U.S. National Institute of Health, 2008. http://www.cancer.gov/ cancertopics/pdq/screening/prostate/ healthprofessional/ allpages#Section-20
21. National Cancer Institute: Prostate Cancer Treatment: Treatment Option Overview, Patient Version, U.S. National Institute of Health, 2008. http://www.cancer.gov/cancertopics/pdq/treatment/ prostate/patient/allpages
22. Saigal CS, Gornbein J, Nease R, et al: Predictors of utilities for health states in early stage prostate cancer. J Urol 166:942-946, 2001
23. Wolf AM, Nasser JF, Wolf AM, et al: The impact of informed consent on patient interest in prostate-specific antigen screening. Arch Intern Med 156:1333-1336, 1996
24. Chan EC, Sulmasy DP: What should men know about prostate-specific antigen screening before giving informed consent? Am J Med 105:266-274, 1998
25. Cancer Screening: A decision guide for African Americans. Atlanta, GA, CDC publication 99-6792, 2007
26. The PSA decision: What you need to know. Hanover, NH, Foundation for Informed Medical Decision Making, 2000 (videotape)
27. What you need to know about prostate cancer. National Cancer Institute, NIH publication 05-1576, 2005
28. Holmes-Rovner M, Stableford S, Fagerlin A, et al: Evidence-based patient choice: A prostate cancer decision aid in plain language. BMC Med Inform Decis Mak 5:16-26, 2005
29. Fagerlin A, Holmes-Rovner M, Rovner D, et al: Making the choice: Deciding what to do about early-stage prostate cancer. Lansing, MI, Michigan Cancer Consortium Prostate Cancer Action committee, 2004
30. Fagerlin A, Rovner D, Stableford S, et al: Patient education materials about the treatment of early-stage prostate cancer: A critical review. Ann Intern Med 140:721-728, 2004
31. Taylor KL, Africano NL, Schwartz M, et al: Prostate cancer screening at National Cancer Institute comprehensive and clinical cancer centers. J Natl Cancer Inst 96:414-415, 2004
32. Litwin M, Hays R, Fink A, et al: The UCLA prostate cancer index: Development, reliability, and validity of health-related quality of life measure. Med Care 36:1002-1012, 1998
33. Ritvo P, Irvine J, Naglie G, et al: Reliability and validity of the PORPUS, a combined psychometric and utility-based quality-of-life instrument for prostate cancer. J Clin Epidemiol 58:466-474, 2005
34. Esper P, Mo F, Chodak G, et al: Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate (FACT-P) instrument. Urology 50:920-928, 1997
35. Potosky AL, Harlan LC, Stanford JL, et al: Prostate cancer practice patterns and quality of life: The Prostate Cancer Outcomes Study. J Natl Cancer Inst 91:1719-1724, 1999
36. Barry M, Fowler F, O'Leary M, et al: The American Urological Association symptom index for benign prostatic hyperplasia: The Measurement Committee of the American Urological Association. J Urol 148:1549-1557, 1992
37. Wei JT, Dunn RL, Litwin MS, et al: Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56:899-905, 2000
38. American Cancer Society: Managing Incontinence After Treatment for Prostate Cancer. American Cancer Society Pamphlet 98-80-No. 4535-CC, 1998
39. Questions and Answers About the Prostate-Specific Antigen (PSA) Test. Washington, DC, National Cancer Institute, 2000. http://cis.nci.nih.gov/ fact/5-29.htm
40. Spradley J: Asking Descriptive Questions, The Ethnographic Interview. Belmont, CA, Wads-worth Group, 1979, pp 78-91
41. Mercer SL, Goel V, Levy IG, et al: Prostate cancer screening in the midst of controversy: Canadian men's knowledge, beliefs, utilization and future intentions. Canadian Journal of Public Health 88: 327-332, 1997
42. Davis T, Long S, Jackson R, et al: Rapid estimate of adult literacy in medicine: A shortened screening instrument. Fam Med 25:391-395, 1993
43. Rosner B: Fundamentals of Biostatistics. Boston, MA, PWS-Kent Publishing Company, 1990
44. Krippendorf K: Content Analysis: An Introduction to Its Methodology. Beverly Hills, CA, Sage, 1980
45. Morse JM: Critical Issues in Qualitative Research Methods. Thousand Oaks, CA, Sage, 1994
46. Rubin HJ, Rubin IS: Qualitative Interviewing: The Art of Hearing Data. Thousand Oaks, CA, Sage, 1995
47. Strauss AL: Qualitative Analysis for Social Scientists. Cambridge, MA, Cambridge University Press, 1987
48. Strauss AL, Corbin J: Basics of Qualitative Research. Newbury Park, CA, Sage, 1990
49. U.S. Census Bureau: Census 2000 Urban and Rural Classification. http://www.census.gov/geo/ www/ua/ua-2k.html
50. Health literacy: Report of the Council on Scientific Affairs: Ad Hoc Committee on Health Literacy for the Council on Scientific Affairs, American Medical Association. JAMA 281:552-557, 1999
51. Gazmararian JA, Baker DW, Williams MV, et al: Health literacy among Medicare enrollees in a managed care organization. JAMA 281:545-551, 1999
52. Rothman RL, DeWalt DA, Malone R, et al: Influence of patient literacy on the effectiveness of a primary care-based diabetes disease management program. JAMA 292:1711-1716, 2004
53. Nielsen-Bohlman L, Panzer AM, Kindig DA: Health Literacy: A Prescription to End Confusion. Washington, DC, National Academies Press, 2004
54. Berkman ND, DeWalt DA, Pignone MP, et al: Literacy and Health Outcomes: Evidence Report / Technology Assessment No. 87 (Prepared by RTI International-University of North Carolina Evidence-based Practice Center under contact # 290-02-0016), (ed Evidence Rep). Rockville, MD, Agency for Healthcare Research and Quality, 2004
55. Mosenthal PB, Kirsch IS: A new measure of assessing document complexity: The PMOSE/ IKIRSCH document readability formula. J Adol Adult Lit 41:638-657, 1998
56. Woloshin S, Schwartz LM, Welch HG: The effectiveness of a primer to help people understand risk: Two randomized trials in distinct populations. Ann Intern Med 146:256-265, 2007
57. Schwartz LM, Woloshin S, Welch HG: Can patients interpret health information? An assessment of the medical data interpretation test. Med Decis Making 25:290-300, 2005
58. Schwartz LM, Woloshin S, Black WC, et al The role of numeracy in understanding the benefit of screening mammography. Ann Intern Med 127:966-972, 1997
59. Lipkus IM: Numeric, verbal, and visual formats of conveying health risks: Suggested best practices and future recommendations. Med Decis Making 27:696-713, 2007
60. Lipkus IM, Klein WM, Rimer BK: Communicating breast cancer risks to women using different formats. Cancer Epidemiol Biomarkers Prev 10:895-898, 2001
61. Lipkus IM, Samsa G, Rimer BK: General performance on a numeracy scale among highly educated samples. Med Decis Making 21:37-44, 2001
62. Centers for Disease Control and Prevention Scientific and technical information simply put. Atlanta, GA, Office of Communication, 1999
63. Ong LM, de Haes JC, Hoos AM, et al: Doctor-patient communication: A review of the literature. Soc Sci Med 40:903-918, 1995
64. Hadlow J, Pitts M: The understanding of common health terms by doctors, nurses and patients. Soc Sci Med 32:193-196, 1991
65. Bourhis RY, Roth S, MacQueen G: Communication in the hospital setting: A survey of medica and everyday language use amongst patients, nurses and doctors. Soc Sci Med 28:339-346, 1989
66. Gibbs RD, Gibbs PH, Henrich J: Patient understanding of commonly used medical vocabulary. J Fam Pract 25:176-178, 1987
67. American Cancer Society: Detailed Guide: Prostate Cancer Surgery, 2008. http://www.cancer org/docroot/CRI/content/CRI-2-4-4X-Surgery-36asp?sitearea
68. Binson D, Catania J: Respondents' understanding of the words used in sexual behavior questions. Public Opin Q 62:190-208, 1998
69. Krahn M, Ritvo P, Irvine J, et al: Patient and community preferences for outcomes in prostate cancer: Implications for clinical policy. Med Care 41:153-164, 2003